Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
---|
01/29/1997 | EP0723453A4 Method of treating reproductive disorders |
01/29/1997 | CN1141630A Substituted pyrazolyl benzenesulfonamides for treating inflammation |
01/28/1997 | US5597894 Multi-tyrosinated somatostatin analogs |
01/28/1997 | US5597797 Administering growth hormone and insulin-like growth factor |
01/28/1997 | US5597709 Human growth hormone splice variants hGHV-2(88) and hGHV-3(53) |
01/28/1997 | CA2039194C Uses of l-deprenyl and compositions for same |
01/23/1997 | WO1997002248A1 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |
01/23/1997 | WO1996040072A3 Composition for sustained release of human growth hormone |
01/22/1997 | EP0754456A2 Topical application of ST1435 as a contraceptive agent |
01/22/1997 | EP0754048A1 Treatment of partial growth hormone insensitivity syndrome |
01/22/1997 | EP0754041A1 Novel substituted tryptamines, phenalkylamines and related compounds |
01/22/1997 | CN1141058A In situ modification and manipulation of stem cells of the central nervous system |
01/22/1997 | CN1140605A Channel tropism powder |
01/21/1997 | US5595995 Anticarcinogenic agents |
01/21/1997 | CA2022682C Cycloalkylene azoles, processes for their production and use, and pharmaceutical preparations obtained therefrom |
01/16/1997 | WO1997001579A2 Somatostatin peptides |
01/16/1997 | WO1997001342A1 Pharmaceutical combined preparation, kit and method for hormonal contraception |
01/15/1997 | EP0752882A1 Treatment for juvenile diabetes |
01/15/1997 | CN1140451A Novel indane-2-mercaptoacetylamide disulfide derivs. useful as inhibitors of enkephalinase |
01/14/1997 | US5593884 Oncoprotein protein kinase |
01/14/1997 | US5593658 Medical compositions |
01/09/1997 | WO1997000894A1 Compounds with growth hormone releasing properties |
01/09/1997 | WO1997000868A1 4-phenylaminothiazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives |
01/09/1997 | WO1997000693A1 Novel formulation for peptide release |
01/09/1997 | WO1997000682A1 Compressed dry-granulation desogestrel tablets |
01/09/1997 | CA2224434A1 Compounds with growth hormone releasing properties |
01/09/1997 | CA2222266A1 4-phenylaminothiazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives |
01/08/1997 | EP0751769A1 Medical treatment using thyroid hormones |
01/08/1997 | CN1033752C (1H-A201-1Ylmethyl) ubstituted quinoline, quinazoline or quinoxaline derivatives |
01/03/1997 | WO1997000079A1 P-selectin ligands and related molecules and methods |
01/03/1997 | CA2224625A1 P-selectin ligands and related molecules and methods |
01/02/1997 | EP0750502A1 Use of phosphorus derivatives of alkaloids for treating endocrinopathies |
01/02/1997 | DE19525017A1 Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption Pharmaceutical Kombinatonspräparat, kit and method for hormonal contraception |
12/27/1996 | WO1996041620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
12/27/1996 | WO1996041523A1 Fgf9 as a specific ligand for fgfr3 |
12/27/1996 | EP0750044A2 DNA constructs and transfection of cells therewith for homologous recombination |
12/27/1996 | EP0749751A2 Pharmaceutical composition for use in tteatment of diabetes |
12/27/1996 | CA2224229A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
12/25/1996 | CN1138853A 1,5-benzodiazepine derivatives useful as CCK or gastrin antagonists |
12/25/1996 | CN1138472A Presciption and prepn. technique of "Ruzengning", for treatment of hyperplasia of mammary glands |
12/24/1996 | US5587497 19-nor-vitamin D compounds |
12/24/1996 | US5587496 15,15-dialkyl-substituted derivatives of estradiol |
12/19/1996 | WO1996040775A1 Method for the treatment of corticosteroid induced osteopenia |
12/19/1996 | WO1996040757A2 Lhrh antagonist peptides |
12/19/1996 | WO1996040640A1 BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION |
12/19/1996 | WO1996040184A1 New cryptophycins from synthesis |
12/19/1996 | WO1996040072A2 Composition for sustained release of human growth hormone |
12/19/1996 | WO1996040048A2 Novel uses for thyroid hormones or thyroid hormone-like compounds |
12/19/1996 | CA2223832A1 Method for the treatment of corticosteroid induced osteopenia |
12/19/1996 | CA2223436A1 Composition for sustained release of human growth hormone |
12/18/1996 | EP0748317A1 Novel thiazolidin-4-one derivatives |
12/18/1996 | CN1138335A Compounds with growth hormone releasing properties |
12/18/1996 | CN1138334A Compounds with growth hormone releasing properties |
12/17/1996 | US5585404 3,5,3'-triiodothyronine receptor ligands |
12/17/1996 | US5585376 1,5-benzodiazepine derivatives having CCK and/or gastrin antagonistic activity |
12/12/1996 | WO1996039400A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists |
12/12/1996 | WO1996039372A2 Macrophage lipid chemoattractant |
12/12/1996 | WO1996039162A1 Regulation of eating behavior |
12/12/1996 | WO1996039161A1 Multi-tyrosinated somatostatin analogs |
12/12/1996 | WO1996039158A1 Pineal gland specific gene-1 |
12/12/1996 | WO1996039140A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
12/12/1996 | WO1996019458A3 Steroid receptor modulator compounds and methods |
12/12/1996 | CA2223307A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists |
12/12/1996 | CA2223153A1 Regulation of eating behavior |
12/12/1996 | CA2222962A1 Multi-tyrosinated somatostatin analogs |
12/12/1996 | CA2222040A1 Macrophage lipid chemoattractant |
12/12/1996 | CA2221842A1 Alpha 1a adrenergic receptor antagonists |
12/11/1996 | EP0747346A2 N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics |
12/11/1996 | CN1137525A Naphthyl compounds, intermediates, compositions, and methods |
12/10/1996 | US5583138 Reductase inhibitor; skin disorders |
12/10/1996 | US5583130 Benzo-fused lactams promote release of growth hormone |
12/08/1996 | CA2176854A1 N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics |
12/05/1996 | WO1996038471A1 Dipeptides which promote release of growth hormone |
12/05/1996 | WO1996038167A1 Use of fibroblast growth factors to stimulate bone growth |
12/04/1996 | EP0745081A1 Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase |
12/04/1996 | EP0745080A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
12/04/1996 | EP0744944A1 Sexual steroid-containing transdermal therapeutic systems |
12/04/1996 | EP0744943A1 Desogestrel-containing transdermal application agent |
12/04/1996 | EP0440738B1 Treatment of hypertension |
12/03/1996 | US5580878 Treating sleep disorders |
12/03/1996 | US5580723 Comparing the activities of a segment-substituted polypeptide and the parent polypeptide; borrowing receptor binding properties from functionally divergent hormones |
12/03/1996 | US5580572 Styrene-isoprene-styrene copolymer-based transdermal matrix system for the administration of an oestrogen and/or a progestogen |
11/28/1996 | WO1996037514A1 Chimeric fatty body-pro-grf analogs with increased biological potency |
11/28/1996 | DE19517145C1 Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron Transdermal therapeutic system (TTS) for the administration of testosterone |
11/27/1996 | CN1136779A Long-acting injection suspensions and process for their preparation |
11/27/1996 | CN1136562A Estrogen excitant/antagonist |
11/26/1996 | US5578724 Process for preparation of benzo[f]quinolinones |
11/26/1996 | US5578588 Nasal administration of a precursor |
11/20/1996 | CN1136318A 16-substituted -4-aza-androstane 5-alpha-reductase isoazyne 1 inhibitors |
11/20/1996 | CN1136278A Combination of bisphosphonates and growth hormone secretagogues |
11/14/1996 | WO1996035950A1 Inhibition of amylin release |
11/14/1996 | WO1996035427A1 Transdermal therapeutic system for administering testosterone |
11/14/1996 | WO1996015148A3 Low molecular weight peptidomimetic growth hormone secretagogues |
11/14/1996 | CA2220358A1 Transdermal therapeutic system (tts) for the administration of testosterone |
11/14/1996 | CA2220106A1 Inhibition of amylin release |
11/13/1996 | EP0741578A1 Human growth hormone |
11/13/1996 | CN1135488A Application of 19,11 beta-bridged sterodal compound in pharmaceutical working |
11/12/1996 | US5574190 Naphthyl compounds, intermediates, compositions, and methods |
11/12/1996 | US5574006 Nasally administrable peptide compositions on hydroxyapatite carriers |
11/05/1996 | US5571925 Angiotensin II antagonists |